abstract |
The present invention provides compositions and methods for treating cancer or a metastasis thereof in a subject. A combination of at least two immune stimulators is used for the treatment including an alpha thymosin peptide and a PD-1 inhibitor, and/or optionally one or more additional anti-cancer agents. |